RLYB biotech catalysts & pipeline

RALLYBIO CORP · Data as of 2026-09-08

Upcoming catalysts

AVZO-023 — Interim data

late 2026

Avenzo plans to present preliminary, updated data of AVZO-023 in combination with fulvestrant from the Phase 1 portion of the ORION-1 study in late 2026.

Source filing

AVZO-103 — Initial data

late 2026

Avenzo plans to present preliminary, updated data from the Phase 1 portion of the AVENTINE-1 study and initial data from the Phase 1 portion of the BEACON-1 study in late 2026.

Source filing

AVZO-1418 — Interim data

late 2026

Avenzo plans to present preliminary, updated data from the Phase 1 portion of the AVENTINE-1 study and initial data from the Phase 1 portion of the BEACON-1 study in late 2026.

Source filing

AVZO-021 — Initial data

2H 2027

• 2H 2027: Initial Phase 1 data in combination with AVZO-023 (CDK4i) and fulvestrant

Source filing

AVZO-023 — Initial data

2H 2027

• 2H 2027: Initial Phase 1 data in combination with AVZO-021 (CDK2i) and fulvestrant

Source filing

AVZO-1418 — Interim data

2H 2027

• Updated AVENTINE-1 Phase 1 data • 2H 2027

Source filing

Explore the free biotech catalyst calendar